Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease'

Neurobiology of Aging

Volumn 19, Issue 2, 1998, Pages 109-116

  Davies, Peter ^b   Resnick, Judith ^b   Resnick, Burton ^b   Gilman, Sid ^c   Growdon, John ^a   Khachaturian, Zaven S ^d   Radebaugh, Teresa S ^d   Roses, Allen D ^e   Selkoe, Dennis J ^f   Trojanowski, John Q ^c,g,t   Blass, John P ^h   Gibson, Gary E ^h   Sheu, K F R ^h   Blennow, Kaj ⁱ   Delacourte, Andre ^j   Frisoni, Giovanni B ^k   Jefferies, Wilfred A ^l   McRae, Amanda ^m   Wisniewski, H M ⁿ   Mehta, P D ⁿ   Pirttla, T ⁿ   Parshad, Ram ^o   Scinto, Leonard F M ^f   Scheltens, Philip ^p   Riekkinen, Paavo J ^q   Soininen, Hilkka S ^q   Swanwick, Gregory R J ^r   Wahlund, Lars Olof ^s   Arnold, S E ^t   Winblad, Bengt ^s   Ihara, Yasuo ^u   Yamazaki, Tsuneo ^u   Arai, Hiroyuki ^v   Clark, Christopher M ^v   Ewbank, Douglas C ^v   Takase, Sadao ^v   Higuchi, Susumu ^v   Mirua, Masakazu ^v   Seki, Hisatomo ^v   Higuchi, Makoto ^v   Matsui, Toshifumi ^v   Lee, Virginia M Y ^v   Sasaki, Hidetata ^v   Foster, Norman L ^c   Galasko, Douglas ^w   Hock, Christoph ^x   Hyman, Bradley T ^y   St George Hyslop, P H ^z   Iwatsubo, Takeshi ^aa   Kennard, Malcolm ^l   Klunk, William E ^ab   Lannfelt, Lars ^s   Litvan, Irene ^ac   Mayeux, Richard ^ad   Robles, Alfredo ^ae   Fabian, V A ^af   Jones, T M ^af   Wilton, S D ^af   Dench, J E ^af   Davis, M R ^af   Lim, L ^af   Kakulas, B A ^af   Kennard, M L ^af   Feldman, H ^af   Yamada, T ^af   Sweet, R A ^af   Zubenko, G S ^af   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d ALZHEIMER'S ASSOCIATION   (United States)

^e GLAXOSMITHKLINE   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ Swedish Medical Research Council   (Sweden)

^j INSERM   (France)

^k GERIATRIC RESEARCH GROUP   (Italy)

^l UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^m UNIVERSITY OF GOTHENBURG   (Sweden)

ⁿ NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^o HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^p ACADEMIC MEDICAL CENTER   (Netherlands)

^q UNIVERSITY OF EASTERN FINLAND   (Finland)

^r ST JAMES S HOSPITAL   (Ireland)

^s KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^t UNIVERSITY OF PENNSYLVANIA   (United States)

^u UNIVERSITY OF TOKYO   (Japan)

^v TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x UNIVERSITY OF BASEL   (Switzerland)

^y HARVARD MEDICAL SCHOOL   (United States)

^z UNIVERSITY OF TORONTO   (Canada)

^aa UNIVERSITY OF TOKYO   (Japan)

^ab UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^ac NATIONAL INSTITUTES OF HEALTH   (United States)

^ad Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^ae HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^af University of Santiago ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BIOCHEMICAL MARKER; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; CONFERENCE PAPER; HUMAN; MOLECULAR GENETICS; MUTATION; NEUROPATHOLOGY; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; HUMANS; MOLECULAR BIOLOGY; NERVE TISSUE PROTEINS;

EID: 0032033832     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00022-0     Document Type: Conference Paper

References (33)

1. 1. Saunders, A. M.; Hulette, C.; Welsh-Bohmer, K. A., et al. Specificity, sensitivity, and predictive value of apolipoprotein E genotyping for sporadic Alzheimer's disease. Lancet 348:90-93; 1996.
2. 2. Saunders, A. M.; Strittmatter, W. J.; Schmechel, D., et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-72; 1993.
3. 3. Mayeux, R.; Saunders, A. M.; Shea, S., et al. Utility of the Apolipoprotein-E Genotype in the diagnosis of Alzheimer's disease. New Engl. J. Med. 338:506-511; 1998.
4. 4. Welsh-Bohmer, K. A.; Gearing, M.; Saunders, A. M., et al. Apolipoprotein E Genotype in a Neuropathological Series from the Consortium to Establish a Registry for Alzheimer's Disease. Ann. Neurol. 42:319-325; 1997.
5. 5. Galasko, D.; Chang, L.; Motter, R., et al. High CSF tau and low A(42 in the clinical diagnosis of Alzheimer's disease and relation to APOE genotype. Arch. Neurol. (in press).
6. 6. Motter, R.; Vigo-Pillrey, C.; Kholodenko, D.; Barbour, R.; Johnson-Wood, K.; Galasko, D.; Chang, L.; Miller, B.; Clark, C.; Green, R., et al. Reduction of beta-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol. 38:643-648; 1995.
7. 7. Tamaoka, A.; Sawamura, N.; Fukushima, T.; Shoji, S.; Matsubara. E.; Shoji. M.; Hirai, S.; Furiya, Y.; Endoh, R.; Mori, H. Amyloid b-protein 42 (43) in cerebrospinal fluid of patients with Alzheimer's disease. J. Neurol. Sci. 148:41-45; 1997.
8. 8. Scheuner, D.; Eckman, C.; Jensen, M.; Song, X.; Citron, M.; Suzuki, N.; Bird, T. D.; Hardy, J.; Hutton, M.; Kukull, W.; Larson, E.; Levy-Lahad, E.; Viitanen, M.; Peskind, E.; Poorkaj, P.; Schellenberg, G.; Tanzi, R. E.; Wasco, W.; Lannfelt, L.; Selkoe, D.; Younkin, S. Aβ42(43) is increased in vivo by the PS1/2 and APP mutations linked to familial Alzheimer's disease. Nature Medicine 2:864-870; 1996.
9. 9. Arai, H.; Nakagawa, T.; Kosaka, Y.; Higuchi, M.; Matsui, T.; Okamura, N.; Sasaki, H. Elevated cerebrospinal fluid tau protein level as a predictor of dementia in memory-impaired individuals. Alzheimer's Res. 3:211-213; 1997.
10. 10. Clark, C. M.; Ewbank, D.; Lee, V.; Trojanowski, J. Q. Molecular pathology of Alzheimer's disease: Neuronal cytoskeletal abnormalities. In: Growdon, J. H.; Rossor, M., eds., The Dementias. Newton, MA: Butterworth Heinemann; (in press).
11. 11. Trojanowski, J. Q.; Clark, C. M.; Arai, H.; Lee, V. Elevated levels of tau in cerebrospinal fluid: Implications for the antemortem diagnosis of Alzheimer's disease. Alzheimer's Disease Review 1:77-83; 1996.
12. 12. de la Monte, S. M.; Ghanbari, K.; Frey, W. H.; Beheshti, I.; Averback, P.; Hauser, S. A.; Ghanbari, H. A.; Wands, J. R. Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid. J. Clin. Invest. 100:3093-3104; 1997.
13. 13. de la Monte, S. M.; Volicer, L.; Hauser, S. L.; Wands, J. R. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol. 32:733-742; 1992.
14. 14. de la Monte, S. M.; Wands, J. R. Neuronal thread protein over-expression in brains with Alzheimer's disease lesions. J. Neurol. Sci. 113:152-164; 1992.
15. 15. Beal, M. F.; Growdon, J. H. CSF neurotransmitter markers in Alzheimer's disease. Prog. Neuro-psycholpharmacol. & Biol. Psychiat. 10:259-270; 1986.
16. 16. Beal, M. F.; Growdon, J. H.; Mazurek, M. F.; Martin, J. B. CSF somatostatin-like immunoreactivity in dementia. Neurology 36:294-297; 1986.
17. 17. Terry, R. D.; Davies, P. Dementia of the Alzheimer type. Ann. Rev. Neurosci. 3:77-95; 1980.
18. 18. Davis, R. E.; Miller, S.; Hernstadt, C.; Ghosh, S. S.; Fahy, E.; Parker, W. D. Jr. Mutations in mitochondrial cytochrome C oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 94:4526-31; 1997.
19. 19. Etcheberrigaray, R.; Ito, E.; Oka, K.; Tofel-Grehl, B.; Gibson, G. E.; Alkon, D. L. Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:8209-13; 1993.
20. 20. Gasparini, L.; Benussi, L.; Curti, D.; Racchi, M.; Govoni, S.; Bianchetti, A.; Trabucchi, M.; Ginetti, G. Inhibition of energy metabolism alters APP secretion in Alzheimer's disease fibroblasts. Soc. Neurosci. Abs. 23:332-3; 1997.
21. 21. Govonl, S.; Bergamaschi, S.; Racchi, M.; Battaini, F.; Binetti, G.; Bianchetti, A.; Trabucchi, M. Cytosol protein kinase C down regulation in fibroblasts from Alzheimer's disease patients. Neurology 43:2581-86; 1993.
22. 22. Growdon, J. H.; Graefe, K.; Tennis, M.; Hayden, D.; Schoenfeld, D.; Wray, S. H. Pupil dilation to tropicamide is not specific for Alzheimer disease. Arch. Neurol. 54:841-44; 1997.
23. 23. Hirashima, N.; Etchabarrigaray, R.; Bergamaschi, S.; Racchi, M.; Battaini, F.; Binetti, G.; Govoni, S.; Alkon, D. L. Calcium responses in human fibroblasts: A diagnostic Molecular profile for Alzheimer's disease. Neurobiol. Aging 17:549-55; 1996.
24. 24. Joachim, C. T.; Mori, H.; Selkoe, D. L. Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease. Nature 341:226-30; 1989.
25. 25. Kennard, M. L.; Feldman, H.; Yamada, T.; Jeffries, W. A. Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease. Nature Med. 2:1230-35; 1996.
26. 26. Kish, S. J.; Bergeron, C.; Rojput, A.; Dozic, 9.; Mastrogiacomo, F.; Chang, L.-J.; Wilson, J. M. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59:776-9; 1992.
27. 27. Parker, W. D. Jr.; Filley, C. M.; Parks, J. K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40:1302-3; 1990.
28. 28. Scinto, L. F.; Daffner, K. R.; Dressler, D., et al. A potential noninvasive neurobiological test for Alzheimer's disease. Science 266:1051-54; 1994.
29. 29. Talamo, B.; Feng, W.-H.; Perez-Cruet, L.; Adelmen, L.; Kosik, K.; Lee, V.M.-Y.; Cork, L. C.; Kauer, J. S. Pathologic changes in olfactory neurons of Alzheimer's disease. Ann. N. Y. Acad. Sci. 640:1-7; 1991.
30. 30. Wallace, D. C.; Stugard, C.; Murdock, D.; Schurn, T.; Brown, M. D. Ancient mtDNA sequence in the human nuclear genome: A potential source of errors in identifying pathogenic mutations. Proc. Natl. Acad. Sci. USA 94:14900-14905; 1997.
31. 31. Zubenko, G. S.; Cohen, B. M.; Boller, F.; Malinakova, M. S.; Chojnacki, B. Platelet membrane abormality in Alzheimer's disease. Ann. Neurol. 22:237-44; 1987.
32. 32. Zubenko, G. S.; Cohen, R. M.; Growdon, J. H.; Corkin, S. Cell membrane abnormality in Alzheimer's disease. Lancet 2:236; 1984.
33. 33. Zubenko, G. S.; Teply, M. S.; Winwood, E.; Huff, T. J.; Moossy, J.; Sunderland, T.; Martinez, A. J. Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: Results at 6 years. Am. J. Psychiatry 153:420-23; 1996.